SCHEMBL22353034

SCHEMBL22353034

C=C(C)C(=O)Oc1ccc2c(c1)C(=C)c1ccccc1-2

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.51
KMT2A Q03164 3/20 0.41
ATM Q13315 1/20 0.41
MAPT P10636 4/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
BACE1 P56817 2/20 0.36
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
S100A4 P26447 1/20 0.34
PDK2 Q15119 1/20 0.33
MAPK1 P28482 1/20 0.33
PTPN1 P18031 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22345623 0.94 ELANE (0.49) ELANEKMT2AATMMAPTALDH1A1
SCHEMBL22352941 0.88 ELANE (0.44) ELANEKMT2AATMMAPTBACE1
SCHEMBL22353041 0.85 ELANE (0.46) ELANEKMT2AATMMAPTSMN1; SMN2
SCHEMBL23637659 0.85 ELANE (0.51) ELANEKMT2AATMMAPTALDH1A1
SCHEMBL27053111 0.84 ELANE (0.41) ELANEKMT2AATMMAPT
SCHEMBL10489364 0.83 ELANE (0.53) ELANEKMT2AATMMAPTALDH1A1
SCHEMBL24377872 0.83 ELANE (0.40) ELANEKMT2AATMMAPTSMN1; SMN2
SCHEMBL22353033 0.83 ELANE (0.40) ELANEKMT2AATMMAPTSMN1; SMN2
SCHEMBL22353025 0.83 MAPT (0.41) ELANEKMT2AATMMAPTALDH1A1
SCHEMBL22353042 0.82 ELANE (0.48) ELANEKMT2AATMMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685863-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-06-27 US disclosed
US-11685863-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-06-27 US disclosed
US-20220127532-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2022-04-28 US disclosed
WO-2020165394-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2020-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127532-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS LPXN, VCL, LCP1 ELANE 1153/4885KMT2A 2566/4885ATM 1563/4885
US-11685863-B2 Polymerisable compounds and the use thereof in liquid-crystal displays LPXN, VCL, LCP1 ELANE 1153/4885KMT2A 2566/4885ATM 1563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.